Saturday 01 Oct, 2022 03:43 AM
Site map | Locate Us | Login
   Dilip Buildcon gains on emerging as L-1 bidder for Rs 723-cr project    Dish TV India Ltd leads losers in 'A' group    Akshar Spintex Ltd leads losers in 'B' group    Goa Carbon temporarily shuts Goa unit    Volumes spurt at Caplin Point Laboratories Ltd counter    Mahindra & Mahindra Ltd soars 1.16%    Punjab & Sind Bank gains for third consecutive session    Indian Overseas Bank gains for third straight session    Sun Pharmaceuticals Industries Ltd spurts 1.46%, rises for third straight session    HCL Technologies Ltd gains for fifth session    Bajaj Finance gains on bargain buying    Heritage Foods spurts after board approves rights issue     CMI Ltd leads gainers in 'B' group    Zydus Lifesciences arm gets 2 observations from USFDA    Nestle India ED and CFO David McDaniel resigns 
Saravan Stocks
Hot Pursuit
Scrips, which has significant changes during the market hours.
Indoco Remedies to acquire stake in Kanakal Wind Energy
17-Aug-22   10:44 Hrs IST

The company has entered into a power purchase agreement with Kanakal Wind Energy and a share purchase and shareholders' agreement between First Energy and Kanakal Wind Energy.

The cost of acquisition of 26% stake in Kanakal Wind Energy is Rs 86.40 lakh. Post acquisition, it will become associate company of Indoco Remedies as the company will hold 26% of shares in Kanakal Wind Energy while remaining 74% will be held by First Energy.

The purpose of entering into the agreements is to establish the solar power plant at Akkalkot, Solapur District in the state of Maharashtra wherein the power generated will be supplied exclusively to Indoco Remedies under the captive rules. The Plant will be established and operated by Kanakal Wind Energy (power producer).

Kanakal Wind Energy is a special purpose vehicle created under captive scheme and was incorporated on 27th March, 2017. It is engaged in the business of developing, building, and managing solar power assets. It has not started commercial production yet.

Indoco Remedies is a fully integrated, research-oriented pharma company with presence in 55 countries. The company reported 2.7% fall in consolidated net profit to Rs 38.57 crore despite of 3.6% rise in net sales to Rs 395.21 crore in Q1 FY23 over Q1 FY22.

Shares of Indoco Remedies slipped 1.62% to currently trade at Rs 355.20 on the BSE.

Powered by Capital Market - Live News

   Attention Investors : Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day........issued in the interest of investors.
   Attention Investors : Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers / Depository Participant. Receive information of your transactions directly from Exchange / Depositories on your mobile / email at the end of the day .... Issued in the interest of Investors.
   Attention Investors : KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
   Attention Investors : No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
Email ID:       Customers grievances :     Compliance officer : Mr.R Udayakumar ,,  Mobile No: 7305522205
Hit Count : 22551770
SEBI Regn.Nos : NSE/BSE-INZ000192638 | CDSL : IN-DP-262-2016  |  MCX : INZ000081736
Member IDs : NSE : 11221 | BSE : 6292 | CDSL : 12045000 | MCX : 12815 | AMFI Regn.No : 2662
Designed , Developed & Content provided by CMOTS INFOTECH.(ISO 9001:2015 certified) © Copyright 2011 All Rights Reserved. Saravana Stocks Pvt. Ltd